Showing 301-310 of 1457 results for "".
When Disruption Spells Opportunity
https://practicaldermatology.com/topics/practice-management/when-disruption-spells-opportunity/20950/Making the case for teledermatology in the new millennium.New Sunscreens Make a Splash in 2017
https://practicaldermatology.com/topics/skin-cancer-photoprotection/new-sunscreens-make-a-splash-in-2017/20721/May is National Skin Care Awareness Month. Time to get up to date on sunscreen innovations.Rising Skin Cancer Rates are a Global Reality
https://practicaldermatology.com/topics/general-topics/PD1009_04-php/20367/One group of researchers questions the skin cancer epidemic, but the overwhelming evidence suggests that rates are rising.Interoperability Update
https://practicaldermatology.com/topics/practice-management/interoperability-update/20674/Are PHRs the key to interoperability?Scurvy in the Modern Era
https://practicaldermatology.com/topics/general-topics/scurvy-in-the-modern-era/21456/One of the winning presentations given by dermatology residents at Cosmetic Surgery Forum.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21819/A First Look at Rotational Fractional Resection
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-first-look-at-rotational-fractional-resection/20383/A new technology offers a fresh approach to treatment of submental contouring.Six Pillars: Assess the Health and Growth of Your Practice
https://practicaldermatology.com/topics/practice-management/six-pillars-assess-the-health-and-growth-of-your-practice/20372/How to monitor your practice's wellness in order to make better strategic decisions.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20924/Biologics for Psoriasis: A Status Update
https://practicaldermatology.com/topics/psoriasis/biologics-for-psoriasis-a-status-update/23006/The field has grown substantially from the early 2000s to include now a dozen innovator systemic agents, a host of biosimilars, and soon JAK Inhibitors.